About our research
Our aim is to find tools for early detection, protection and treatments and ways to individualize the risk assessment for each patient. Our research program has developed from clinical issues.
The group is active at Heartlab Novum, which is part of the Clinical Research Center Huddinge. We cooperate with other groups from the Department of Laboratory Medicine (LABMED),the Department of Oncology-Pathology (ONK-PAT), the Department of Medicine Solna (MedS) and SciLife Lab.
heart failure, cardio-oncology, cardiomyocyte, endothelial cell, differentiation, early detection
- iPSC derived cardiomyocytes and cardiotoxicity assessment
- Endothelial injury after cancer treatment
- Risk assessment of cardiovascular side effects of cancer treatment
- Spatial transcriptomics in fetal cardiac development